{"name":"ProJenX","slug":"projenx","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"prosetin","genericName":"prosetin","slug":"prosetin","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"prosetin","genericName":"prosetin","slug":"prosetin","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxPMVhacVdwVHVVNkdIRXlrTmJCV0lRU3EzdlZLdHZZWlBJT0ZTbDVvNUR4Y3o3cmdGRmtnamhJZEdMc3lybEZteGdrT2pYZUJFYm1WMnoxSUt2ejFJbmU1aGtWd2YtLW9fNFlXU1RZZ3dRbER4bDdBTWJudGFOY3NuUGswcHNrSF80TE80b0Njd3NjTTNQSlFvWXo1V1pEVEQ5elBjYVl4TTZWWXhxbTFOLXBZVU5xaF9BZmNGU3RGVjVHM0V0VEUxMFI3M3g5M0ZhR3lVM19XNUp2VnpubjFOWnRzTzk4cGwwVzJGdFNiZ3pVOUFXLWtDZkx6TkI0clR0OVhKUTdMSFlRdUpKQ3MtY2FCSlV5Y1p3V0lZbjNKOTRQZHFqRXhXTEYzbHc1M3UtMnhIMzBvSUlPVURzcHg5N3BrS1VseUVaVkg5NVQ5TTVSUQ?oc=5","date":"2026-03-04","type":"regulatory","source":"Barchart","summary":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | COSCIENS Biopharma, BenevolentAI, Verge Genomics, ProJenX - ","headline":"Amyotrophic Lateral Sclerosis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approval","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7wFBVV95cUxPVHpqTlBVSXNQUXA0dk9nb0F4clVfOHpsNTRXVEdfLXZMOXIzZV91VW81cExVX1hBUDk4X1lsWmxQTkNlR2RsQzlhcVJOUkZHd1dMWW9vR0lBV0xFLVFzZkE0dE5XdXNHZmJCZmFVVUlVYVdGVUlHdDdhMnliRlJjaHV0ckc4SW1pSVJKS29DX3lTc0dieENhcHJfekZpdVlRREhyZE90S3Qxalg3bWQ1U2R2Qm9TUVNvRzYzeUtaTktGSWtvWkd5WVhkSGVQMTZ2d3ZzWFViR05BNS1aeW0zZ0dnVm5BZnVxLTA2dC1yRQ?oc=5","date":"2024-09-26","type":"trial","source":"PR Newswire","summary":"ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model - PR Newswire","headline":"ProJenX and Unlearn Announce Partnership to Augment ALS Clinical Trial PRO-101 with Digital Twin Model","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPbXhTN2YyVE0zYUJZdWNWa0EtSFpjcWpPZUxYOHhOMm1uMl91Q0NfVjNBWWx1WEV4TWdNRHUtN19JTWJYLTV0V29iY1VwSlBVX2hzT3lJMXlDLVVhSnI5dlhzX2N5c2p6NTU1WFVzd0xQNGpQaTZoVnVZTXZiSzdjZks2QmlUaFprYVppOE9iRzZORlVWNmVmb0NveUc?oc=5","date":"2024-03-29","type":"regulatory","source":"Fierce Biotech","summary":"ProJenX ALS treatment gets back on the map after partial FDA hold - Fierce Biotech","headline":"ProJenX ALS treatment gets back on the map after partial FDA hold","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPdFpRbDR3ZzZObmh5VmhFRFhUU0J4NVJRSV9xb1g4b3B6bjBKQ2kzVHNRYU4yMzhuUldjRTNaUEZ0TjZBSG00Zzk4QnUwa0Y4RVlyTWtsMVFyLTdzWEU2UGdVVEt6U0NySkZqbW9vZlZrSjRFTHBpVWNSdE5ER05EZA?oc=5","date":"2023-11-07","type":"pipeline","source":"ALS News Today","summary":"ProJenX receives $15M in funding to further develop prosetin for ALS - ALS News Today","headline":"ProJenX receives $15M in funding to further develop prosetin for ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOcmpzSWMzcklVNC12VEJCTzlmQmpoOUJleUJZd3ZpVVp1YWtac3ZnYnBjaG9sM1g1NUtxbnUxYTNERDZseGJhV1V2ZU4zVm80ZTBWbEhaQXJhSGdBWHBnNU4tMzFjRWFqYlF1ZTVrRnpTdFpqcXczRUZIWlVQTUZqejlJLXozYzIyc3JiY1lVUXRKWW9LWVBTcm9pb1dhTURJQ3FvZnlDLVFZQzVId0pfR2JTRVA5ZngzaVBYZTZaekZIOWFjaTB6UC1mWFhPVGZPWmdQdDdSUjl0YkE0WlZ6cW9jaU5BeGlyN2JSaUpZUG9SRzQ?oc=5","date":"2023-11-02","type":"pipeline","source":"PR Newswire","summary":"ProJenX Announces Initial Closing of $15M Series A Financing and Appoints Rick Hartz to Board of Directors - PR Newswire","headline":"ProJenX Announces Initial Closing of $15M Series A Financing and Appoints Rick Hartz to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxQZldwb1FhLUxydmp5eVZ0NTJpUHFBbTZVWjNRa0M0RHpGQkJvTlNfWmxoekh3YWtxbDU0Z2t4YUFyVUtoa2lkbHhyZm9iOGNtVEF1dTdHU1diZGFHNm5CemdsTXJjZlhnbGFXYTdNQ0hhdlRqQ3RXU3hJWXZyWUZtRWNXdlVuZ241eWZzaVVWNE5VeldLRjNRZWE5Z3d0VXpGTVhvQWpmUVIzNVU?oc=5","date":"2022-11-16","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Stress Test: ProJenX’s Oral Drug Shows Early Promise vs. ALS - Genetic Engineering and Biotechnology News","headline":"Stress Test: ProJenX’s Oral Drug Shows Early Promise vs. ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9LMkRUYVhxNzZyX3V6RmNCVloyTEZud2NMU243SldCekVkVzBCSUxMM3UyUW1pVkdTbVJ3cUJqaFBYNFBLTmtaMUpDX0Z1V3NzUnpzT3liS3FYNzVmQnZab0p0N0lzRmp0SnBHSFFielVUUUhJcDlSODdBVG8?oc=5","date":"2022-05-18","type":"pipeline","source":"citybiz","summary":"ProJenX Appoints Stan Abel as CEO - citybiz","headline":"ProJenX Appoints Stan Abel as CEO","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}